Abstract
Purpose
Werner syndrome (WS) is a rare autosomal recessive genetic disease caused by mutations in the WRN gene, and it is characterized by multiple manifestations corresponding to early-onset aging. This study reports the case of a WS patient with a novel WRN mutation.
Patient and methods
A 36-year-old male patient with WS was evaluated after approval from the local ethics committee. The clinical and biochemical findings of the patient were described. Peripheral blood sample was collected to extract genomic DNA for WRN gene exome sequencing. The three-dimensional (3D) protein structural prediction analysis was performed via the AlphaFold 2.2 program and PyMol software.
Results
We report the case of a clinically diagnosed WS patient with consanguineous parents who presented with complex manifestations including early-onset diabetes mellitus, binocular cataracts, cerebral infarction, cerebral atherosclerosis, hypertension, dyslipidemia, hypothyroidism, and suspected meningioma, accompanied by short stature, gray hair, rough skin with subcutaneous fat atrophy, a high-pitched voice, palmoplantar keratoderma, bilateral flat feet, and an indolent deep ulceration on the foot. Exome sequencing identified a novel homozygous frameshift mutation in the WRN gene, c.666-669 del TATT, p.I223fs. The 3D structure prediction showed that premature termination and significant structural changes could occur in the mutant WRN protein.
Conclusion
We identified a novel homozygous frameshift mutation, p.I223fs, in WRN in a Chinese patient with WS, expanding the spectrum of mutations in WS.
References
C.J. Epstein, G.M. Martin, A.L. Schultz, A.G. Motulsky, Werner’s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 45, 177–221 (1966)
M. Goto, Hierarchical deterioration of body systems in Werner’s syndrome: implications for normal ageing. Mechan. Ageing Dev. 98, 239–254 (1997)
M. Goto, K. Tanimoto, Y. Horiuchi, T. Sasazuki, Family analysis of Werner’s syndrome: a survey of 42 Japanese families with a review of the literature. Clin. Genet. 19, 8–15 (1981)
M. Koshizaka, Y. Maezawa, Y. Maeda, M. Shoji, H. Kato et al. Time gap between the onset and diagnosis in Werner syndrome: a nationwide survey and the 2020 registry in Japan. Aging 12, 24940–24956 (2020)
C.E. Yu, J. Oshima, Y.H. Fu, E.M. Wijsman, F. Hisama et al. Positional cloning of the Werner’s syndrome gene. Science 272, 258–262 (1996)
D.L. Croteau, V. Popuri, P.L. Opresko, V.A. Bohr, Human RecQ helicases in DNA repair, recombination, and replication. Annu. Rev. Biochem. 83, 519–552 (2014)
J. Oshima, J.M. Sidorova, R.J. Monnat Jr., Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions. Ageing Res. Rev. 33, 105–114 (2017)
M. Takemoto, S. Mori, M. Kuzuya, S. Yoshimoto, A. Shimamoto et al. Diagnostic criteria for Werner syndrome based on Japanese nationwide epidemiological survey. Geriatr. Gerontol. Int. 13, 475–481 (2013)
S. Huang, L. Lee, N.B. Hanson, C. Lenaerts, H. Hoehn et al. The spectrum of WRN mutations in Werner syndrome patients. Hum. Mutat. 27, 558–567 (2006)
Y. Nakamura, T. Shimizu, Y. Ishikawa, T. Matsumoto, M. Sugimoto et al. Triple primary sarcoma in Werner syndrome with a novel mutation. Rheumatology 42, 798–800 (2003)
J. Jumper, R. Evans, A. Pritzel, T. Green, M. Figurnov et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021)
X. Wang, S. Liu, F. Qin, Q. Liu, Q. Wang, Werner syndrome presenting as early-onset diabetes: a case report. J. Diabetes Investig. 13, 592–598 (2022)
Y. Kubota, M. Takemoto, T. Taniguchi, S.I. Motegi, A. Taniguchi et al. Management guideline for Werner syndrome 2020. 6. Skin ulcers associated with Werner syndrome: prevention and non-surgical and surgical treatment. Geriatr. Gerontol. Int. 21, 153–159 (2021)
B. Jaafar, M. Nasrallah, B. Sievers, J. Oshima, D. Lessel, Werner syndrome in a Lebanese family. Am. J. Med. Genet. Part A 188, 1630–1634 (2022)
S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015)
J.J. Perry, S.M. Yannone, L.G. Holden, C. Hitomi, A. Asaithamby et al. WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing. Nat. Struct. Mol. Biol. 13, 414–422 (2006)
K. Kitano, N. Yoshihara, T. Hakoshima, Crystal structure of the HRDC domain of human Werner syndrome protein, WRN. J. Biol. Chem. 282, 2717–2728 (2007)
T. Suzuki, M. Shiratori, Y. Furuichi, T. Matsumoto, Diverged nuclear localization of Werner helicase in human and mouse cells. Oncogene 20, 2551–2558 (2001)
J.M. Lauper, A. Krause, T.L. Vaughan, R.J. Monnat Jr., Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS One 8, e59709 (2013)
Acknowledgements
The authors would like to thank the patient for his contribution and cooperation with the study. We also thank Clinical Medical Experimental Research Center of Fujian Provincial Hospital for providing support of DNA sequencing. The computations in the study were performed on the π2.0 cluster supported by the Center for High Performance Computing of Shanghai Jiao Tong University.
Author contributions
J.Wu, S.P., R.L. and G.C. contributed to the design of the study. S.P., J.Wu, W.L. and J.Wen collected the clinical data. R.L. performed the sequence analysis. J.Wu and S.P. wrote the draft of the manuscript. R.L. and G.C. jointly supervised the work. All the authors have read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
The study was approved by the Ethics Committee of Fujian Provincial Hospital, Fuzhou, China (No. K2016-10-032).
Informed consent
Written informed consent was obtained from the patient included in the study for genome sequencing and publication.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wu, J., Pan, S., Lin, W. et al. The identification of a novel mutation (p.I223fs) in WRN associated with Werner syndrome. Endocrine 84, 92–96 (2024). https://doi.org/10.1007/s12020-023-03565-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03565-7